Top-News

Egalet News

Keine aktuellen Kursdaten verfügbar
WKN: A1XD5Z
ISIN: US28226B1044
US-Symbol: EGLTQ
Typ: Aktie

Egalet News

19.11.18 - PR Newswire
Egalet Reports Third Quarter 2018 Financial Results
Egalet Reports Third Quarter 2018 Financial Results -- Highest quarterly revenue for SPRIX Nasal Spray and OXAYDO -- PR Newswire
08.08.18 - PR Newswire
Egalet Reports Second Quarter 2018 Financial Results
Egalet Reports Second Quarter 2018 Financial Results --Improvements in formulary status for key products-- --Company to host conference call today at 8:30 AM EDT-- PR Newswire
25.07.18 - PR Newswire
Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018
Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018 PR Newswire
07.06.18 - PR Newswire
Egalet Appoints Industry Veteran John Varian to Board of Directors
Egalet Appoints Industry Veteran John Varian to Board of Directors PR Newswire
04.06.18 - PR Newswire
Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference
Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference PR Newswire
29.05.18 - PR Newswire
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray PR Newswire
08.05.18 - PR Newswire
Egalet Reports First Quarter 2018 Financial Results
Egalet Reports First Quarter 2018 Financial Results --Multiple advances in formulary status for key products-- --Realigned and re-​focused sales force-- --Company to host ...
07.05.18 - PR Newswire
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER --SPRIX Nasal Spray placed in preferred position-- --Plan covers 3.5 million ...
30.04.18 - PR Newswire
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse PR Newswire
17.04.18 - PR Newswire
Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER in Preferred Formulary Position
Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER in Preferred Formulary Position PR Newswire
21.03.18 - PR Newswire
Egalet to Present at Upcoming Conferences
Egalet to Present at Upcoming Conferences PR Newswire
12.03.18 - PR Newswire
Egalet Reports Fourth Quarter and Full Year 2017 Financial Results
Egalet Reports Fourth Quarter and Full Year 2017 Financial Results -- 120 percent combined prescription growth 2017 over 2016 -- -- 55 percent net product sales growth 2017 over ...
28.02.18 - PR Newswire
Egalet Announces a Large Regional Health Plan Placed ARYMO® ER and SPRIX® Nasal Spray in Preferred Formulary Positions
Egalet Announces a Large Regional Health Plan Placed ARYMO® ER and SPRIX® Nasal Spray in Preferred Formulary Positions PR Newswire
26.02.18 - PR Newswire
Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 12, 2018
Egalet to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 12, 2018 PR Newswire
20.02.18 - PR Newswire
Egalet Announces Issuance of New U.S. Patent for Guardian™ Technology
Egalet Announces Issuance of New U.S. Patent for Guardian™ Technology PR Newswire
01.02.18 - PR Newswire
Egalet to Participate in Panel at BIO CEO & Investor Conference
Egalet to Participate in Panel at BIO CEO & Investor Conference PR Newswire
29.01.18 - PR Newswire
Egalet Announces ARYMO® ER Data Published in Current Medical Research and Opinion Journal
Egalet Announces ARYMO® ER Data Published in Current Medical Research and Opinion Journal --Data help clinicians interpret abuse-​deterrent studies-- PR Newswire
24.01.18 - PR Newswire
Egalet to Co-Host Category 1 Focus Group
Egalet to Co-Host Category 1 Focus Group --Attendees to discuss best practices in Category 1 abuse-​deterrent studies-- PR Newswire
23.01.18 - PR Newswire
Egalet's Partner OraPharma Begins Promotion of SPRIX® Nasal Spray
Egalet's Partner OraPharma Begins Promotion of SPRIX® Nasal Spray -- Doubles the promotional effort behind SPRIX -- PR Newswire
03.01.18 - PR Newswire
Egalet Partners with OraPharma to Co-Promote SPRIX® Nasal Spray
Egalet Partners with OraPharma to Co-​Promote SPRIX® Nasal Spray PR Newswire

Newssuche

Videos

newspaper
26.04.24 +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »